|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|---|---|---|---|---|
| Current assets: | |||||||
| Cash and cash equivalents | |||||||
| Restricted cash | |||||||
| Short term investments | |||||||
| Prepaid expenses | |||||||
| Due from related parties | |||||||
| Other current assets | |||||||
| Total current assets | |||||||
| Digital assets, at fair value | |||||||
| Long-term portion of prepaid expenses | |||||||
| Operating lease right of use asset, net | |||||||
| Property and equipment, net | |||||||
| Total assets | |||||||
| Current liabilities: | |||||||
| Accrued interest – related party | |||||||
| Related Party | |||||||
| Total accrued interest – related party | |||||||
| Notes payable – related party | |||||||
| Accounts payable and accrued expenses | |||||||
| Accrued offering costs | |||||||
| Accrued interest - related party | |||||||
| Accrued interest | |||||||
| Accrued interest — related party | |||||||
| Advance payable to related party | |||||||
| Notes payable - related party | |||||||
| Warrant Liability | |||||||
| Notes payable, net | |||||||
| Related Party | |||||||
| Total notes payable, net | |||||||
| Derivative liability | |||||||
| Convertible notes, net | |||||||
| Related Party | |||||||
| Total convertible notes, net | |||||||
| Operating lease liability | |||||||
| Total current liabilities | |||||||
| Long term portion of notes payable – related party | |||||||
| Long term portion of convertible notes payable – related party | |||||||
| Long-term liabilities | |||||||
| Long-term portion of operating lease liability | |||||||
| Long-term convertible notes payable – related party | |||||||
| Total liabilities | |||||||
| Shareholders’ equity: | |||||||
| Preferred stock, par value $0.001, 10,000,000 shares authorized; 747,702 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | |||||||
| Common stock, par value $0.001, 100,000,000 shares authorized; 1,509,118 and 1,257,598 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||
| Common Shares to be issued | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total shareholders’ equity (deficit) | |||||||
| Total liabilities and shareholders’ equity |
Loading...